Table 1.
Reference | Species | Technique | Setting | Biofluid/Tissue | Discriminate Metabolites/Metabolism |
---|---|---|---|---|---|
Li et al., 2015 | LDLR-/- mice | NMR, GC-FID/MS | Atherosclerosis | Plasma, urine | Significant drop in PUFA-to-MUFA (and PUFA-to-UFA) ratios in both the plasma and liver of WD-fed mice |
C57BL/J6 mice | Liver, Kidney and myocardial Tissue | ||||
Chouchani et al., 2014 | C57BL/6J mice | LC-MS | Ischemia-reperfusion injury | Heart | Significant increase in succinate |
Lu et al., 2017 | Human | QTOF/MS | Coronary Heart Disease | Plasma | glycerophospholipid metabolism including phosphatidylcholine, lysophosphatidylcholine (lysoPC), phospha- tidylethanolamine, lysophosphatidylethanolamine (lysoPE), phos- phatidylserine, lysophosphatidylserine, phosphatidylino- sitol, and lysophosphatidic acids. Among them, lysoPC (20:0), lysoPC (20:1), lysoPC (20:2), lysoPC (20:5), lysoPC (22:5), lysoPE (18:3), and glycerophosphocholine |
Wang et al., 2017 | Sprague-Dawley rats | UPLC-TOF/MS | Pulmonary Arterial Hypertension | Right Ventricular Tissue | Significant increase in oxidized glutathione, xanthine and uric acid and a reduction in α-tocopherol nicotinate |
Varvarousis et al., 2017 | Landrace/large-white pigs | NMR, LC-MS/MS | Asphyxial cardiac arrest | Plasma | Significant increase in succinate |
NMR, 1H Nuclear magnetic resonance spectroscopy; GC-FID/MS, gas chromatography with flame ionization detection – mass spectrometry; LC-MS, liquid chromatography – mass spectrometry; QTOF/MS, quadrupole time of flight mass spectrometry; UPLC-TOF/MS, ultra performance liquid chromatography – time of flight mass spectrometry; PUFA, poly-unsaturated fatty acids; MUFA, mono-unsaturated fatty acids; UFA, unsaturated fatty acids; WD, western diet; LysoPC, lysophosphatidylcholine.